2015•Current Opinion in Critical CareRequires access

Current and future status of extracorporeal life support for respiratory failure in adults

Robert H. Bartlett, Kristopher B. Deatrick

Abstract

PURPOSE OF REVIEW: The purpose is to review the development and current application of extracorporeal life support [ECLS, extracorporeal membrane oxygenation (ECMO)] in acute severe respiratory failure. RECENT FINDINGS: Extracorporeal support (ECMO) is used for acute severe respiratory failure in advanced ICUs. The current survival rate is 60-70%. Three controlled trials all demonstrated 20-30% improvement in survival compared to conventional care. Patients may now be maintained awake and ambulatory with spontaneous breathing. SUMMARY: ECMO is the next step in the algorithm for management of severe respiratory failure unresponsive to conventional care.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Extracorporeal membrane oxygenation, Extracorporeal, Life support, Intensive care medicine, Respiratory failure, Acute respiratory failure, Ambulatory